Evidence map›Paper›PMID 41625379›Full record

ArticleMaterials today. Bio2025

Corrigendum to "Attenuation of blood-brain barrier dysfunction by functionalized gold nanoparticles against amyloid-β peptide in an Alzheimer's disease-on-a-chip model" [Mater. Today Bio 35 (2025) 102453].

Andreas Arellano, Sujey Palma-Florez, Pablo Cabrera, Elizabeth Cortés-Adasme, Karen Bolaños, Freddy Celis, Aurora J Araya-Vergara, Melina Pérez, Andrés Crespo, Maycol Huerta Matus and 7 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Andreas ArellanoNanobioengineering Group, Institute for Bioengineering of Catalonia (IBEC) Barcelona Institute of Science and Technology (BIST), 12 Baldiri Reixac 15-21, Barcelona, 08028, Spain.
Sujey Palma-FlorezNanobioengineering Group, Institute for Bioengineering of Catalonia (IBEC) Barcelona Institute of Science and Technology (BIST), 12 Baldiri Reixac 15-21, Barcelona, 08028, Spain.
Pablo CabreraDepartamento de Química Farmacológica y Toxicológica, Facultad de Cs. Qcas. y Farmacéuticas, Universidad de Chile, Chile.
Elizabeth Cortés-AdasmeDepartamento de Química Farmacológica y Toxicológica, Facultad de Cs. Qcas. y Farmacéuticas, Universidad de Chile, Chile.
Karen BolañosDepartamento de Química Farmacológica y Toxicológica, Facultad de Cs. Qcas. y Farmacéuticas, Universidad de Chile, Chile.
Freddy CelisInstituto de Química, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, Av Brasil 2950, Valparaíso, Chile.
Aurora J Araya-VergaraDepartamento de Química Farmacológica y Toxicológica, Facultad de Cs. Qcas. y Farmacéuticas, Universidad de Chile, Chile.
Melina PérezNanobioengineering Group, Institute for Bioengineering of Catalonia (IBEC) Barcelona Institute of Science and Technology (BIST), 12 Baldiri Reixac 15-21, Barcelona, 08028, Spain.
Andrés CrespoNanobioengineering Group, Institute for Bioengineering of Catalonia (IBEC) Barcelona Institute of Science and Technology (BIST), 12 Baldiri Reixac 15-21, Barcelona, 08028, Spain.
Maycol Huerta MatusDepartamento de Ciencias Quimicas, Facultad de Ciencias Exactas, Universidad Andres Bello, Republica 275, Santiago, Chile.
Eyleen ArayaDepartamento de Ciencias Quimicas, Facultad de Ciencias Exactas, Universidad Andres Bello, Republica 275, Santiago, Chile.
Rebeca AldunateBiotecnología, Facultad de Ciencias, Universidad Santo Tomás, Chile.
Marcelo J KoganDepartamento de Química Farmacológica y Toxicológica, Facultad de Cs. Qcas. y Farmacéuticas, Universidad de Chile, Chile.
Josep SamitierNanobioengineering Group, Institute for Bioengineering of Catalonia (IBEC) Barcelona Institute of Science and Technology (BIST), 12 Baldiri Reixac 15-21, Barcelona, 08028, Spain.
Anna LagunasNanobioengineering Group, Institute for Bioengineering of Catalonia (IBEC) Barcelona Institute of Science and Technology (BIST), 12 Baldiri Reixac 15-21, Barcelona, 08028, Spain.
Mònica MirNanobioengineering Group, Institute for Bioengineering of Catalonia (IBEC) Barcelona Institute of Science and Technology (BIST), 12 Baldiri Reixac 15-21, Barcelona, 08028, Spain.
Natalia HassanInstituto Universitario de Investigación y Desarrollo Tecnológico (IDT), Universidad Tecnológica Metropolitana, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.mtbio.2025.102453.].

Identifiers

PMID41625379
PMCPMC12859665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.